At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2 enrolled
Drug / intervention
Percutaneous epidural stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Explore the Use of Percutaneous Spinal Stimulation in Participants With Multiple Sclerosis
In Brief
A clinical study evaluating Percutaneous epidural stimulation for Multiple Sclerosis and 2 related conditions. Completed, enrolled 2 participants across 1 site.
Detailed Summary
A study to quantify changes in motor performance of epidural stimulation in progressive multiple sclerosis (MS) patients over the course of 12 rehabilitation sessions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMayo Clinic
Timeline
N/ACompletedFinished
202420252026
First PostedAug 2023
Enrollment StartSep 2023
Primary CompletionFeb 2024
TodayJul 2026
First PostedAug 31, 2023
Enrollment StartSep 11, 2023
Primary CompletionFeb 27, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 2.8 years ago
Interventions
Percutaneous epidural stimulationdevice
Abbott percutaneous trial lead for epidural neurostimulation (Model 3086) Abbott clinician programmer for epidural and dorsal root ganglion neurostimulation (Model 3874) Ripple Neuromed Nomad Neurostimulation System